|
A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high dose cisplatin chemotherapy to reduce ototoxicity. |
|
|
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Kura Oncology (Inst); Merck (Inst); Regeneron (Inst); Sanofi (Inst) |
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline; Merck; Regeneron; Sanofi |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Merck KGaA |
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Honoraria - AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Janssen Oncology; Mirati Therapeutics; Pfizer; Takeda |
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Genentech; Mirati Therapeutics; Regeneron; Takeda |
|
|
Employment - Decibel Therapeutics |
Leadership - Decibel Therapeutics |
Stock and Other Ownership Interests - Decibel Therapeutics |
Research Funding - Decibel Therapeutics |
Patents, Royalties, Other Intellectual Property - Decibel Therapeutics |
Travel, Accommodations, Expenses - Decibel Therapeutics |
|
|
Employment - Praxis Precision Medicines |
Stock and Other Ownership Interests - Praxis Precision Medicines |
Consulting or Advisory Role - Avalo Therapeutics; Axial Therapeutics; Decibel Therapeutics; Fulcrum Therapeutics; Sionna Therapeutics |
Travel, Accommodations, Expenses - Axial Therapeutics; Decibel Therapeutics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - 4M Therapeutics; Lapuerta Consulting |
Leadership - 4M Therapeutics |
Stock and Other Ownership Interests - 4M Therapeutics; Lexicon |
Consulting or Advisory Role - Capsida Biotherapeutics; Decibel Therapeutics; Encuragen; NextPhase Therapeutics; ProventionBio; TerSera; Viacyte; Youngene Therapeutics |
Patents, Royalties, Other Intellectual Property - 4M Therapeutics Inc. |
|
|
Stock and Other Ownership Interests - Cochlear |
Research Funding - Decibel Therapeutics |